These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8790482)
1. Preventing manifestations of hereditary haemochromatosis through population based screening. Haddow JE; Ledue TB J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482 [TBL] [Abstract][Full Text] [Related]
2. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980 [TBL] [Abstract][Full Text] [Related]
3. Population screening for haemochromatosis: a unifying analysis of published intervention trials. Bradley LA; Haddow JE; Palomaki GE J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481 [TBL] [Abstract][Full Text] [Related]
7. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. Bradley LA; Haddow JE; Palomaki GE J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence of hereditary hemochromatosis among healthy workers. Diagnostic value of transferrin saturation assay]. Martínez-Vázquez C; Martínez Cadilla J; Gil M; Sopeña B; Torres J; Cordeiro E; Seijas M; de la Fuente J; Méndez MJ An Med Interna; 2000 Dec; 17(12):628-31. PubMed ID: 11213576 [TBL] [Abstract][Full Text] [Related]
9. Hereditary hemochromatosis. Crownover BK; Covey CJ Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762 [TBL] [Abstract][Full Text] [Related]
11. Testing for haemochromatosis in the diabetic clinic. George DK; Evans RM; Crofton RW; Gunn IR Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282 [TBL] [Abstract][Full Text] [Related]
12. Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity. Wiggers P; Dalhøj J; Hyltoft Petersen P; Blaabjerg O; Hørder M Scand J Clin Lab Invest; 1991 Apr; 51(2):143-8. PubMed ID: 2042019 [TBL] [Abstract][Full Text] [Related]
13. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557 [TBL] [Abstract][Full Text] [Related]
15. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness. Adams PC; Kertesz AE; Valberg LS Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485 [TBL] [Abstract][Full Text] [Related]
17. Screening for genetic haemochromatosis in a rheumatology clinic. Olynyk J; Hall P; Ahern M; Kwiatek R; Mackinnon M Aust N Z J Med; 1994 Feb; 24(1):22-5. PubMed ID: 8002853 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic efficacy of screening tests for hereditary hemochromatosis. Borwein S; Ghent CN; Valberg LS Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of 5 patients with possible primary hemochromatosis]. Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652 [TBL] [Abstract][Full Text] [Related]
20. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis. Milman N; Albeck MJ Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]